Literature DB >> 31847589

αKlotho attenuates cardiac hypertrophy and increases myocardial fibroblast growth factor 21 expression in uremic rats.

Paulo Giovani de Albuquerque Suassuna1,2, Paula Marocolo Cherem1, Bárbara Bruna de Castro1, Edgar Maquigussa3, Marco Antonio Cenedeze3, Júlio Cesar Moraes Lovisi2, Melani Ribeiro Custódio4, Helady Sanders-Pinheiro1,2, Rogério Baumgratz de Paula1,2.   

Abstract

Entities:  

Keywords:  Chronic kidney disease; FGF21; FGF23; Klotho; uremic cardiomyopathy

Mesh：

Substances：

Year:  2019        PMID： 31847589      PMCID： PMC6987748          DOI： 10.1177/1535370219894302

Source DB:  PubMed          Journal:  Exp Biol Med (Maywood)        ISSN： 1535-3699


× No keyword cloud information.
  65 in total

1.  Analysis of relative gene expression data using real-time quantitative PCR and the 2(-Delta Delta C(T)) Method.

Authors:  K J Livak; T D Schmittgen
Journal:  Methods       Date:  2001-12       Impact factor: 3.608

2.  Induction of antioxidant genes by sulforaphane and klotho in human aortic smooth muscle cells.

Authors:  Benedetta Rizzo; Giuseppe Maltese; Maria Psefteli Paraskevi; Silvana Hrelia; Giovanni Mann; Richard Siow
Journal:  Free Radic Biol Med       Date:  2014-12-10       Impact factor: 7.376

3.  Uremic cardiomyopathy in hemodialysis patients.

Authors:  B Nik-Akhtar; H Khonsari; A Hesabi; M Khakpour
Journal:  Angiology       Date:  1978-10       Impact factor: 3.619

4.  Comparison of the protective properties of four clinical crystalloid cardioplegic solutions in the rat heart.

Authors:  L A Robinson; M V Braimbridge; D J Hearse
Journal:  Ann Thorac Surg       Date:  1984-09       Impact factor: 4.330

5.  Klotho Protects Against Indoxyl Sulphate-Induced Myocardial Hypertrophy.

Authors:  Ke Yang; Cheng Wang; Ling Nie; Xiaohui Zhao; Jun Gu; Xu Guan; Song Wang; Tangli Xiao; Xinli Xu; Ting He; Xuefeng Xia; Junping Wang; Jinghong Zhao
Journal:  J Am Soc Nephrol       Date:  2015-03-24       Impact factor: 10.121

6.  Klotho and phosphate are modulators of pathologic uremic cardiac remodeling.

Authors:  Ming Chang Hu; Mingjun Shi; Han Jun Cho; Beverley Adams-Huet; Jean Paek; Kathy Hill; John Shelton; Ansel P Amaral; Christian Faul; Masatomo Taniguchi; Myles Wolf; Markus Brand; Masaya Takahashi; Makoto Kuro-O; Joseph A Hill; Orson W Moe
Journal:  J Am Soc Nephrol       Date:  2014-10-17       Impact factor: 10.121

7.  Fibroblast growth factor 21 protects against cardiac hypertrophy in mice.

Authors:  A Planavila; I Redondo; E Hondares; M Vinciguerra; C Munts; R Iglesias; L A Gabrielli; M Sitges; M Giralt; M van Bilsen; F Villarroya
Journal:  Nat Commun       Date:  2013       Impact factor: 14.919

8.  Circulating FGF21 levels are progressively increased from the early to end stages of chronic kidney diseases and are associated with renal function in Chinese.

Authors:  Zhuofeng Lin; Zhihong Zhou; Yanlong Liu; Qi Gong; Xinxin Yan; Jian Xiao; Xiaojie Wang; Shaoqiang Lin; Wenke Feng; Xiaokun Li
Journal:  PLoS One       Date:  2011-04-15       Impact factor: 3.240

9.  Fibroblast growth factor 21 protects rat cardiomyocytes from endoplasmic reticulum stress by promoting the fibroblast growth factor receptor 1-extracellular signal‑regulated kinase 1/2 signaling pathway.

Authors:  Pingping Liang; Lin Zhong; Lei Gong; Jiahui Wang; Yujie Zhu; Weifeng Liu; Jun Yang
Journal:  Int J Mol Med       Date:  2017-09-19       Impact factor: 4.101

10.  Klotho modulates ER-mediated signaling crosstalk between prosurvival autophagy and apoptotic cell death during LPS challenge.

Authors:  Jennifer Mytych; Przemyslaw Solek; Marek Koziorowski
Journal:  Apoptosis       Date:  2019-02       Impact factor: 5.561
View more
  4 in total

Review 1.  The Protective Role of Klotho in CKD-Associated Cardiovascular Disease.

Authors:  Xianjin Bi; Ke Yang; Bo Zhang; Jinghong Zhao
Journal:  Kidney Dis (Basel)       Date:  2020-08-19

2.  Myocardial Hypertrophy and Fibrosis Are Associated with Cardiomyocyte Beta-Catenin and TRPC6/Calcineurin/NFAT Signaling in Spontaneously Hypertensive Rats with 5/6 Nephrectomy.

Authors:  Evdokia Bogdanova; Olga Beresneva; Olga Galkina; Irina Zubina; Galina Ivanova; Marina Parastaeva; Natalia Semenova; Vladimir Dobronravov
Journal:  Int J Mol Sci       Date:  2021-04-28       Impact factor: 5.923

Review 3.  Clinical Potential of Targeting Fibroblast Growth Factor-23 and αKlotho in the Treatment of Uremic Cardiomyopathy.

Authors:  Jonathan P Law; Anna M Price; Luke Pickup; Ashwin Radhakrishnan; Chris Weston; Alan M Jones; Helen M McGettrick; Winnie Chua; Richard P Steeds; Larissa Fabritz; Paulus Kirchhof; Davor Pavlovic; Jonathan N Townend; Charles J Ferro
Journal:  J Am Heart Assoc       Date:  2020-03-26       Impact factor: 5.501

4.  The anti-aging factor Klotho protects against acquired long QT syndrome induced by uremia and promoted by fibroblast growth factor 23.

Authors:  José Alberto Navarro-García; Rafael Salguero-Bodes; Laura González-Lafuente; Laura Martín-Nunes; Elena Rodríguez-Sánchez; Teresa Bada-Bosch; Eduardo Hernández; Evangelina Mérida-Herrero; Manuel Praga; Jorge Solís; Fernando Arribas; Héctor Bueno; Makoto Kuro-O; María Fernández-Velasco; Luis Miguel Ruilope; Carmen Delgado; Gema Ruiz-Hurtado
Journal:  BMC Med       Date:  2022-01-19       Impact factor: 8.775
  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.